Equity Analyst, LightStream Research

Shifara Samsudeen, ACMA, CGMA

A chartered management accountant with more than 10 years of rich experience in investment research and financial analysis. Worked as an equity analyst for one of the world's largest asset managers with USD2.5trn in AUM covering numerous sectors including chemicals, retail, tech, autos, telco, real-estate and banks, globally. Experienced in fundamental equity research, industry research, commodity studies, forensic accounting, and due diligence reviews.

Equity Analyst

Medlive Tech IPO (Part II): Further Room for Margin Expansion with Expanding Scale

Medlive Technology IPO: Forecasts and Valuation

Shanghai Heartcare IPO: Strong Potential in Treating Strokes

LinkDoc Technology IPO: Big Data for Cancer Care

Didi IPO: Forecasts, Peer Comparison and Valuation

M3: Robust FY03/2021 Earnings Driven by Pandemic; Shares Are Still Expensive Even After Recent Drop

Missfresh IPO: Per Unit Analysis Shows the Company Is Far from Profits

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Capital Markets

Medlive Technology / Equity Capital Markets

<a href="https://www.smartkarma.com/entities/medlive-technology-co-ltd" target="_blank" data-smartkarma-citation="entities:32985:1" rel="noopener">Medlive Technology (MLT HK)</a>  is the largest online professional physician platform in China based on registered physician users in 2020 (Source: Frost &amp; Sullivan). The company generates revenues primarily through offering digital marketing services to pharmaceuticals and healthcare companies, research and education/learning content to physicians and internet hospital services to patients.Medlive has filed for an IPO to list its shares on the Hong Kong Stock Exchange and plans to raise proceeds of about US$500m. The company is backed by the Japanese healthcare and medical-related services platform M3.Medlive is well positioned to benefit from growing demand for digital healthcare marketing and digital healthcare education and information services in China driven by increased health awareness, technological advancements, prevalence of chronic conditions and favourable government policies.In this insight, we discuss in detail Medlive’s business model, segments, industry prospects and the company’s top line growth. In a follow-up insight, we will be discussing the company’s margins.

Medlive Technology (MLT HK)  is the largest online professional physician platform in China based on registered physician users in 2020 (Source: Frost &amp; Sullivan). The company generates revenues primarily through offering digital marketing services to pharmaceuticals and healthcare companies, research and education/learning content to physicians and internet hospital services to patients.Medlive has filed for an IPO to list its shares on the Hong Kong Stock Exchange and plans to raise proceeds of about US$500m. The company is backed by the Japanese healthcare and medical-related services platform M3.Medlive is well positioned to benefit from growing demand for digital healthcare marketing and digital healthcare education and information services in China driven by increased health awareness, technological advancements, prevalence of chronic conditions and favourable government policies.In this insight, we discuss in detail Medlive’s business model, segments, industry prospects and the company’s top line growth. In a follow-up insight, we will be discussing the company’s margins.

Medlive Tech IPO (Part I): Diversified Services and a Major Beneficiary of Digital Healthcare Market